Parasuicidal patients in the emergency department and their relationship with cannabinoid gene polymorphism

Background: Suicidal behavior represents a serious public health problem. Studies about twins, adoption, and family conflicts have shown a relationship between genetics and suicide. CB1 receptors are coded by the cannabinoid-1 receptor (CNR1) gene. It was shown that the CNR1 gene polymorphism (1359 G/A) is associated with many neuropsychiatric disorders, including major depression. Objective: Our aim is to study whether there is an association between the polymorphism of the CNB1 receptor and suicide attempts. We compared non-suicide subjects with suicide-attempt victims to substantiate these findings. Materials and Methods: Peripheral blood samples were drawn from all of the participants, and single nucleotide polymorphism (SNP) of the cannabinoid gene (1359 G/A) was analyzed. Results: The study included 115 suicide attempts (parasuicide patients) (mean age 25.6±8.5; 41 males, 74 females) and 69 unrelated healthy subjects (mean age 27.5±10.6; 38 males, 31 females). The genotype distributions were significantly different between the parasuicide and control groups and this difference was attributed to the AG genotype rates (21.7% vs 44.9%, p=0.001). Having AG genotype lowered the admittance to ED due to parasuicide 3.3 times (95% CI: 1.6-6.8). The frequencies of A and G alleles in the CNR1 gene polymorphism were 16.1%). (n=37) and 83.9% (n=193) in parasuicide patients and 22.5% (n=31) and 77.5% (n=107) in the control group, respectively (p=0.127). All the subjects with the AA genotype were in the parasuicide group (n=6). The frequency of the AG genotype was significantly lower in parasuicide patients with a previous psychiatric diagnosis compared to suicide attempts without a previous diagnosis (32% (n=8) vs. 68% (n=17); p=0.004). Conclusion: There is a preventive association between the CNR1 rs1049353 (1359 G/A) gene polymorphism and parasuicide patients. The CNR1 receptor polymorphism may be used as a biological test to help predict and prevent suicide intentions if the relationship can be proved with further studies.

[1]  P. Moore,et al.  Endocannabinoid system dysfunction in mood and related disorders , 2011, Acta psychiatrica Scandinavica.

[2]  J. Manzanares,et al.  Endocannabinoid System and Psychiatry: In Search of a Neurobiological Basis for Detrimental and Potential Therapeutic Effects , 2011, Front. Behav. Neurosci..

[3]  H. Akiskal,et al.  The possible contributory role of the S allele of 5-HTTLPR in the emergence of suicidality , 2011, Journal of psychopharmacology.

[4]  Young-Min Park,et al.  Cannabinoid type 1 receptor gene polymorphisms are not associated with olanzapine‐induced weight gain , 2011, Human psychopharmacology.

[5]  G. Juhász,et al.  Personalized medicine can pave the way for the safe use of CB₁ receptor antagonists. , 2011, Trends in pharmacological sciences.

[6]  D. D. de Luis,et al.  Roles of G1359A polymorphism of the cannabinoid receptor gene (CNR1) on weight loss and adipocytokines after a hypocaloric diet. , 2011, Nutricion hospitalaria.

[7]  D. D. de Luis,et al.  Influence of G1359A polymorphism of the cannabinoid receptor gene on anthropometric parameters and insulin resistance in women with obesity. , 2011, Metabolism: clinical and experimental.

[8]  M. Krebs,et al.  CNR1 gene polymorphisms in addictive disorders: a systematic review and a meta‐analysis , 2011, Addiction biology.

[9]  M. Moța,et al.  The association of the rs1049353 polymorphism of the CNR1 gene with hypoadiponectinemia. , 2011, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

[10]  D. D. de Luis,et al.  Relation of resistin levels with cardiovascular risk factors, insulin resistance and inflammation in naïve diabetes obese patients. , 2010, Diabetes research and clinical practice.

[11]  V. Arango,et al.  Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides. , 2010, Journal of psychiatric research.

[12]  J. Lieberman,et al.  A Common Polymorphism in the Cannabinoid Receptor 1 (CNR1) Gene is Associated with Antipsychotic-Induced Weight Gain in Schizophrenia , 2010, Neuropsychopharmacology.

[13]  D. D. de Luis,et al.  G1359A polymorphism of the cannabinoid receptor gene (CNR1) and insulin resistance in patients with diabetes mellitus type 2. , 2010, Nutricion hospitalaria.

[14]  G. Juhász,et al.  Promoter variants of the cannabinoid receptor 1 gene (CNR1) in interaction with 5‐HTTLPR affect the anxious phenotype , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[15]  M. Maj,et al.  Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects , 2009, Genes, brain, and behavior.

[16]  L. Bierut,et al.  Evidence for association between polymorphisms in the cannabinoid receptor 1 (CNR1) gene and cannabis dependence , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[17]  Vladimir Carli,et al.  Gene-Environment Interaction and Suicidal Behavior , 2009, Journal of psychiatric practice.

[18]  M. Moța,et al.  The implication of CNR1 gene's polymorphisms in the modulation of endocannabinoid system effects. , 2009, Romanian journal of internal medicine = Revue roumaine de medecine interne.

[19]  M. Olivier,et al.  Genetic variation in cannabinoid receptor 1 (CNR1) is associated with derangements in lipid homeostasis, independent of body mass index. , 2008, Pharmacogenomics.

[20]  T. Meitinger,et al.  Lack of association of genetic variants in genes of the endocannabinoid system with anorexia nervosa , 2008, Child and adolescent psychiatry and mental health.

[21]  M. Hutz,et al.  Cannabinoid Type-1 Receptor Gene Polymorphisms Are Associated with Central Obesity in a Southern Brazilian Population , 2008, Disease markers.

[22]  M. Milders,et al.  Abnormal Temporal Difference Reward-learning Signals in Major Depression Department of Radiology And , 2022 .

[23]  T. Hansen,et al.  Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index in European populations. , 2008, Human molecular genetics.

[24]  G. Serra,et al.  Clinical Practice and Epidemiology in Mental Health a Possible Role for the Endocannabinoid System in the Neurobiology of Depression , 2007 .

[25]  H. Emrich,et al.  No association of CNR1 gene variations with susceptibility to schizophrenia , 2007, Neuroscience Letters.

[26]  R. Puffenbarger,et al.  Genetic Polymorphisms of the Endocannabinoid System , 2007, Chemistry & biodiversity.

[27]  E. Christiansen,et al.  Risk of Repetition of Suicide Attempt, Suicide or all Deaths after an Episode of Attempted Suicide: A Register-Based Survival Analysis , 2007, The Australian and New Zealand journal of psychiatry.

[28]  K. Vinod,et al.  Role of the endocannabinoid system in depression and suicide. , 2006, Trends in pharmacological sciences.

[29]  B. Bondy,et al.  Genetics of suicide , 2006, Molecular Psychiatry.

[30]  V. Arango,et al.  Elevated levels of endocannabinoids and CB1 receptor-mediated G-protein signaling in the prefrontal cortex of alcoholic suicide victims , 2005, Biological Psychiatry.

[31]  K. Hawton,et al.  Value of measuring suicidal intent in the assessment of people attending hospital following self-poisoning or self-injury , 2005, British Journal of Psychiatry.

[32]  J. Hoenicka,et al.  Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1) , 2005, The Pharmacogenomics Journal.

[33]  V. Arango,et al.  Upregulation of CB1 receptors and agonist-stimulated [35S]GTPγS binding in the prefrontal cortex of depressed suicide victims , 2004, Molecular Psychiatry.

[34]  J. Samochowiec,et al.  Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe alcohol dependence. , 2002, Drug and alcohol dependence.

[35]  N. Griffon,et al.  Schizophrenia and the cannabinoid receptor type 1 (CB1): association study using a single-base polymorphism in coding exon 1. , 2001, American journal of medical genetics.

[36]  J. Mann,et al.  Risk of suicide in mood disorders , 2001, Clinical Neuroscience Research.

[37]  K. Müller-Vahl,et al.  A frequent polymorphism in the coding exon of the human cannabinoid receptor (CNR1) gene. , 1999, Molecular and cellular probes.

[38]  H. Möller,et al.  Harte und weiche Methoden des Parasuizids: was bestimmt die Wahl? , 1998 .

[39]  H. Möller,et al.  [Violent and non-violent methods of parasuicide: what determines the choice?]. , 1998, Fortschritte der Neurologie-Psychiatrie.